The global genetic testing market size estimated at USD 24.45 billion in 2025 and is anticipated to reach around USD 65.03 billion by 2034, expanding at a CAGR of 11.50% from 2025 to 2034. The North America genetic testing market is valued at USD 11.82 billion in 2024 and is expanding at a CAGR of 11.54% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Genetic Testing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Genetic Testing Market, by Test Type,
8.1.1. Carrier Testing
8.1.1.1. Market Revenue and Forecast
8.1.2. Predictive Testing
8.1.2.1. Market Revenue and Forecast
8.1.3. Diagnostic Testing
8.1.3.1. Market Revenue and Forecast
8.1.4. Prenatal & Newborn Testing
8.1.4.1. Market Revenue and Forecast
8.1.5. Nutrigenomics
8.1.5.1. Market Revenue and Forecast
8.1.6. Pharmacogenomics
8.1.6.1. Market Revenue and Forecast
8.1.7. Others
8.1.7.1. Market Revenue and Forecast
9.1. Genetic Testing Market, by Disease,
9.1.1. Cancer
9.1.1.1. Market Revenue and Forecast
9.1.2. Alzheimer’s
9.1.2.1. Market Revenue and Forecast
9.1.3. Thalassemia
9.1.3.1. Market Revenue and Forecast
9.1.4. Cystic Fibrosis
9.1.4.1. Market Revenue and Forecast
9.1.5. Huntington’s Disease
9.1.5.1. Market Revenue and Forecast
9.1.6. Duchenne Muscular Dystrophy
9.1.6.1. Market Revenue and Forecast
9.1.7. Others
9.1.7.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Test
10.1.2. Market Revenue and Forecast, by Disease
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Test
10.1.3.2. Market Revenue and Forecast, by Disease
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Test
10.1.4.2. Market Revenue and Forecast, by Disease
10.2. Europe
10.2.1. Market Revenue and Forecast, by Test
10.2.2. Market Revenue and Forecast, by Disease
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Test
10.2.3.2. Market Revenue and Forecast, by Disease
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Test
10.2.4.2. Market Revenue and Forecast, by Disease
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Test
10.2.5.2. Market Revenue and Forecast, by Disease
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Test
10.2.6.2. Market Revenue and Forecast, by Disease
10.3. APAC
10.3.1. Market Revenue and Forecast, by Test
10.3.2. Market Revenue and Forecast, by Disease
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Test
10.3.3.2. Market Revenue and Forecast, by Disease
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Test
10.3.4.2. Market Revenue and Forecast, by Disease
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Test
10.3.5.2. Market Revenue and Forecast, by Disease
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Test
10.3.6.2. Market Revenue and Forecast, by Disease
10.4. MEA
10.4.1. Market Revenue and Forecast, by Test
10.4.2. Market Revenue and Forecast, by Disease
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Test
10.4.3.2. Market Revenue and Forecast, by Disease
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Test
10.4.4.2. Market Revenue and Forecast, by Disease
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Test
10.4.5.2. Market Revenue and Forecast, by Disease
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Test
10.4.6.2. Market Revenue and Forecast, by Disease
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Test
10.5.2. Market Revenue and Forecast, by Disease
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Test
10.5.3.2. Market Revenue and Forecast, by Disease
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Test
10.5.4.2. Market Revenue and Forecast, by Disease
11.1. Genentech Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Sorenson Genomics, LLC
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Abbott Molecular
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bayer Diagnostics
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Biocartis
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. BioHelix
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Celera Genomics
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Genomic Health
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. HTG Molecular Diagnostics
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. PacBio
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample